Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 9 studies | 65% ± 22% | |
| amacrine cell | 7 studies | 38% ± 14% | |
| retinal ganglion cell | 6 studies | 45% ± 22% | |
| retina horizontal cell | 5 studies | 57% ± 4% | |
| GABAergic neuron | 5 studies | 38% ± 15% | |
| retinal bipolar neuron | 4 studies | 32% ± 13% | |
| oligodendrocyte precursor cell | 4 studies | 22% ± 5% | |
| interneuron | 4 studies | 32% ± 14% | |
| neuron | 3 studies | 34% ± 17% | |
| GABAergic amacrine cell | 3 studies | 34% ± 14% | |
| OFF-bipolar cell | 3 studies | 36% ± 15% | |
| rod bipolar cell | 3 studies | 37% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 6268.60 | 2589 / 2642 | 89% | 11.51 | 628 / 705 |
| kidney | 72% | 353.15 | 64 / 89 | 75% | 6.47 | 675 / 901 |
| bladder | 81% | 399.14 | 17 / 21 | 12% | 0.35 | 62 / 504 |
| prostate | 73% | 251.58 | 179 / 245 | 19% | 0.27 | 93 / 502 |
| uterus | 78% | 287.78 | 133 / 170 | 13% | 0.52 | 61 / 459 |
| adrenal gland | 10% | 25.94 | 25 / 258 | 66% | 5.89 | 152 / 230 |
| intestine | 47% | 137.59 | 456 / 966 | 22% | 0.51 | 116 / 527 |
| breast | 65% | 326.09 | 299 / 459 | 2% | 0.04 | 24 / 1118 |
| blood vessel | 65% | 356.35 | 870 / 1335 | 0% | 0 | 0 / 0 |
| heart | 57% | 242.33 | 492 / 861 | 0% | 0 | 0 / 0 |
| adipose | 55% | 362.72 | 660 / 1204 | 0% | 0 | 0 / 0 |
| esophagus | 36% | 107.95 | 522 / 1445 | 13% | 0.34 | 24 / 183 |
| stomach | 34% | 83.49 | 121 / 359 | 15% | 0.37 | 43 / 286 |
| thymus | 14% | 36.85 | 89 / 653 | 7% | 0.11 | 43 / 605 |
| spleen | 15% | 34.37 | 36 / 241 | 0% | 0 | 0 / 0 |
| ovary | 11% | 33.50 | 19 / 180 | 4% | 0.07 | 16 / 430 |
| peripheral blood | 14% | 80.82 | 126 / 929 | 0% | 0 | 0 / 0 |
| pancreas | 2% | 6.31 | 8 / 328 | 6% | 0.11 | 10 / 178 |
| lung | 2% | 3.72 | 10 / 578 | 5% | 0.13 | 56 / 1155 |
| skin | 2% | 6.20 | 45 / 1809 | 2% | 0.33 | 11 / 472 |
| muscle | 4% | 9.14 | 33 / 803 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 3% | 0.13 | 13 / 406 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.18 | 2 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007601 | Biological process | visual perception |
| GO_0042308 | Biological process | negative regulation of protein import into nucleus |
| GO_0005615 | Cellular component | extracellular space |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005938 | Cellular component | cell cortex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0014069 | Cellular component | postsynaptic density |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0008139 | Molecular function | nuclear localization sequence binding |
| GO_0005246 | Molecular function | calcium channel regulator activity |
| GO_0048306 | Molecular function | calcium-dependent protein binding |
| GO_0004857 | Molecular function | enzyme inhibitor activity |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CABP1 |
| Protein name | Calcium-binding protein 1 (CaBP1) (Calbrain) (Caldendrin) Calcium binding protein 1 |
| Synonyms | |
| Description | FUNCTION: Modulates calcium-dependent activity of inositol 1,4,5-triphosphate receptors (ITPRs). Inhibits agonist-induced intracellular calcium signaling . Enhances inactivation and does not support calcium-dependent facilitation of voltage-dependent P/Q-type calcium channels . Causes calcium-dependent facilitation and inhibits inactivation of L-type calcium channels by binding to the same sites as calmodulin in the C-terminal domain of CACNA1C, but has an opposite effect on channel function . Suppresses the calcium-dependent inactivation of CACNA1D (By similarity). Inhibits TRPC5 channels . Prevents NMDA receptor-induced cellular degeneration. Required for the normal transfer of light signals through the retina (By similarity). . |
| Accessions | C9J8G2 ENST00000351200.6 [Q9NZU7-2] Q9NZU7 ENST00000453000.1 ENST00000316803.8 [Q9NZU7-4] ENST00000288616.7 [Q9NZU7-1] |